Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Decision Support to Improve System Naloxone Co-prescribing
Sponsor: University of Colorado, Denver
Summary
The objective of this study is to evaluate the impact of a clinical decision support (CDS) alert to facilitate the co-prescribing of naloxone, an opioid overdose reversal agent, with high-risk opioid prescriptions. Prescribing naloxone with opioids is a best practice described in the 2022 US Center for Disease Control and Prevention (CDC) guidelines on opioid prescribing. The CDS can improve quality of care delivered by improving compliance with the guideline defined best practices. The project will compare CDS alert facilitated co-prescribing of naloxone with high-risk opioid prescriptions vs usual care to evaluate the effectiveness of the CDS alert for improving naloxone prescribing. The patients are not assigned to an intervention and will be receiving any changes in care as part of their routine medical care, rather than a specific intervention that is distinct from their usual medical care. The researchers hypothesize that the CDS alert will be acceptable to providers while increasing naloxone co-prescribing which will reduce the number of opioid overdoses in subsequent 6 months.
Key Details
Gender
All
Age Range
12 Years - 89 Years
Study Type
OBSERVATIONAL
Enrollment
200000
Start Date
2024-07-01
Completion Date
2026-04
Last Updated
2025-12-10
Healthy Volunteers
Yes
Interventions
Naloxone Co-prescribing Clinical Decision Support (CDS)
Clinical decision support in the form of an EHR-integrated, provider facing alert suggesting (a) the opioid medication order is considered high risk for overdose and (b) to nudge providers to add a naloxone prescription to the opioid prescription to mitigate risk in the event of an overdose.
Locations (1)
University of Colorado Hospital
Aurora, Colorado, United States